Detalles de la búsqueda
1.
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies.
Pediatr Blood Cancer
; 68(8): e29087, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34022093
2.
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.
Biol Blood Marrow Transplant
; 24(10): 2040-2046, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29933069
3.
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Blood
; 127(13): 1656-65, 2016 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-26825712
4.
High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomes.
Pediatr Hematol Oncol
; 35(5-6): 316-321, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30681039
5.
Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplant.
Pediatr Blood Cancer
; 64(9)2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28266766
6.
The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients.
J Pediatr Hematol Oncol
; 39(1): 26-32, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27820121
7.
Safety, Pharmacokinetics, and Efficacy of Palifermin in Children and Adolescents with Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Trial.
Biol Blood Marrow Transplant
; 22(7): 1247-1256, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968792
8.
Single Daily Busulfan Dosing for Infants with Nonmalignant Diseases Undergoing Reduced-Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell Transplantation.
Biol Blood Marrow Transplant
; 21(9): 1612-21, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26025482
9.
Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.
Blood
; 119(25): 6155-61, 2012 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22573402
10.
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
Biol Blood Marrow Transplant
; 19(8): 1238-43, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23751955
11.
Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.
Biol Blood Marrow Transplant
; 18(6): 903-12, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22062801
12.
Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo disease.
Pediatr Transplant
; 15(3): 334-43, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21492354
13.
Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(3): 350-7, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20005964
14.
Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia.
Biol Blood Marrow Transplant
; 16(9): 1237-44, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20302960
15.
A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors.
J Neurooncol
; 97(2): 247-55, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19768658
16.
High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival.
Br J Haematol
; 146(6): 669-74, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19650884
17.
Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome in a hematopoietic stem cell transplant recipient.
Pediatr Blood Cancer
; 50(6): 1278-9, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18260119
18.
Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
Pediatr Blood Cancer
; 51(5): 675-8, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18623206
19.
Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Hematol Oncol Stem Cell Ther
; 11(3): 169-174, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29397331
20.
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
J Clin Oncol
; 22(14): 2885-90, 2004 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15254057